Bevacizumab Versus Ranibizumab in Age Related Macular Degeneration
Status:
Unknown status
Trial end date:
2012-02-01
Target enrollment:
Participant gender:
Summary
To report the short term anatomic and visual acuity response after intravitreal injection of
bevacizumab and ranibizumab in patients with choroidal neovascularization secondary to
age-related macular degeneration.